Reference
> Burhop, K, Gordon, D, & Estep, T. (2004). Review of hemoglobin-induced
> myocardial lesions. Artificial cells, blood substitutes, and immobilization
> biotechnology, 32(3), 353-74.
> Jahr, JS, Nesargi, SB, Lewis, K, et al. (2002). Blood substitutes and oxygen
> therapeutics: an overview and current status. American journal of
> therapeutics, 9(5), 437-43.
> Ness, PM, & Cushing, MM. (2007). Oxygen therapeutics: pursuit of an
> alternative to the donor red blood cell. Archives of pathology & laboratory
> medicine, 131(5), 734-41.
> Oxygent™ “[http://www.allp.com/Oxygent/OX.HTM]”. Retrieved on
> 06/04/07.
> Reid, TJ. (2003). Hb-based oxygen carriers: are we there yet?. Transfusion,
> 43(2), 280-7.
> Riess, JG. (2006). Perfluorocarbon-based oxygen delivery. Artificial cells,
> blood substitutes, and immobilization biotechnology, 34(6), 567-80.
> Seeley, Rod. Anatomy and Physiology. 7th ed. 656-658, 704-705. New York,
> NY : McGraw-Hill, 2006
> Winslow, RM. (2004). MP4, a new nonvasoactive polyethylene glycol-
> hemoglobin conjugate. Artificial organs, 28(9), 800-6.
> Winslow, RM. (2006). Current status of oxygen carriers ('blood substitutes'):
> 2006. Vox sanguinis, 91(2), 102-10.
> [http://www.madehow.com/Volume-5/Artificial-Blood.html]. Retrieved on
> 06/04/07.
Figures
www.northfieldlabs.com/images/process.jpg
www5.ha.org.hk/rcbts/images/platelet_1_e.jpg
www.bloodtransfusion.com/blood_gfx/blooddrop.gif
www.freewebs.com/.../red%20blood%20cells.bmp
www.innovationcanada.ca/20/images/blood-z.jpg
www.perfusion.com/.../2561-platelet.jpg